← Back to All Filings

Colgate-Palmolive Chief Growth Officer Receives Equity Incentive Grants

Low SignificanceSeptember 18, 2026 at 9:17:01 PM UTC

COLGATE PALMOLIVE CO

$CL4CIK: 0000021665

Subscribe to track CL

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Colgate-Palmolive Co ($CL) Form 4 Filing SummaryInsider: John Hazlin (Chief Growth Officer) • Transaction Date: September 16, 2026 • Transaction Type: Grant / Award (Code A) • Securities Acquired: 3,908 Restricted Stock Units ($0.00) & 27,042 Stock Options ($87.02 exercise price) • Direct Shares Owned After: 27,021 shares (+5,513 indirect in 401(k)) • Significance: Low (Routine annual/incentive compensation grant)

Comprehensive Analysis

Executive Compensation Overview

On September 18, 2026, Colgate-Palmolive Co ($CL) reported equity incentive awards granted to John Hazlin, the company's Chief Growth Officer, with a transaction date of September 16, 2026.

Transaction Breakdown

  1. Restricted Stock Units (RSUs):

    • Shares Granted: 3,908 shares of Common Stock
    • Price: $0.00 (Incentive Award)
    • Vesting Terms: Vests in three equal annual installments on each of the first, second, and third anniversaries of the grant date.
    • Direct Post-Transaction Holdings: 27,021 shares (in addition to 5,513 shares held indirectly through the issuer's 401(k) plan trustee).
  2. Stock Options (Right to Buy):

    • Underlying Shares: 27,042 shares of Common Stock
    • Exercise Price: $87.02 per share
    • Expiration Date: September 16, 2036
    • Vesting Terms: Becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.

Analysis and Market Significance

This filing reflects a routine equity award granted under Colgate-Palmolive's incentive compensation plan rather than an open-market transaction. Because it is standard executive compensation designed for retention and alignment with long-term shareholder value, it carries Low trading significance.

Topics:#ColgatePalmolive#CL#InsiderTrading#Form4#ExecutiveCompensation

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.